Track Bausch Health Companies Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Bausch Health Companies Inc. BHC.TO · Stock Open Bausch Health Companies Inc. in new tab

7.09 CAD
P/E
13.95
EPS
-4.49
P/B
-0.97
ROE
436.36
Beta
0.41
Loading chart...
Key Metrics
Earnings dateJuly 29, 2026
P/E13.95
EPS-4.49
Book Value-7.61
Price to Book-0.97
Debt/Equity5591.25
% Insiders10.887%
Growth
Revenue Growth0.12%
Estimates
Forward P/E1.30
Forward EPS5.70

DCF Valuation

Tweak assumptions to recompute fair value for Bausch Health Companies Inc. (BHC.TO)
Currency: CAD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Bausch Health Companies Inc. Logo Bausch Health Companies Inc. Analysis (BHC.TO)

Canada Health Care Official Website Stock

Is Bausch Health Companies Inc. a good investment? Bausch Health Companies Inc. (BHC.TO) is currently trading at 7.09 CAD.

In terms of valuation, the stock trades at a P/E ratio of 13.95. This relatively low multiple may signal that Bausch Health Companies Inc. is undervalued compared to historical market norms.

Earnings Schedule: Bausch Health Companies Inc. is expected to release its next earnings report on July 29, 2026. The market consensus estimate for Forward EPS is 5.70.

Investor FAQ

Does Bausch Health Companies Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Bausch Health Companies Inc.?

Bausch Health Companies Inc. is classified as a Stock. You can compare it against 5 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be July 29, 2026. The company currently has a trailing EPS of -4.49.

Company Profile

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Exchange Ticker
MEX (Mexico) BHCN.MX
NYQ (United States) BHC
FRA (Germany) BVF.F
STU (Germany) BVF.SG
TOR (Canada) BHC.TO
Trades
Dividend History paid per year (CAD)
Historical Dividends
Year Total Dividends
2010
1.39 CAD
Dec. 22, 2010 1.0048
Oct. 4, 2010 0.0970
July 5, 2010 0.0970
April 5, 2010 0.0950
Jan. 4, 2010 0.0960
2009
1.11 CAD
Oct. 5, 2009 0.0960
July 6, 2009 0.1060
April 6, 2009 0.4710
Jan. 5, 2009 0.4380
2008
1.15 CAD
Sept. 3, 2008 0.3990
May 30, 2008 0.3790
April 3, 2008 0.3710
2007
2.27 CAD
Nov. 30, 2007 0.4210
Aug. 31, 2007 0.4210
May 29, 2007 0.4210
April 3, 2007 0.4210
Jan. 22, 2007 0.5878
2006
0.57 CAD
Nov. 30, 2006 0.1420
Sept. 1, 2006 0.1400
May 31, 2006 0.1380
April 28, 2006 0.1460
2005
0.60 CAD
Dec. 14, 2005 0.5980
Stock Splits
Split Date Split Ratio to 1
Jan. 10, 2000 2.000000
Oct. 5, 2000 2.000000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion